Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
1 result
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
First-in-human, randomized, double-blind, placebo-controlled, dose escalation trial of the anti-herpes simplex virus monoclonal antibody HDIT101 in healthy volunteers.
Clin Transl Sci. 2022 Oct;15(10):2366-2377. doi: 10.1111/cts.13365. Epub 2022 Jul 23.
Clin Transl Sci. 2022.
PMID: 35869929
Free PMC article.
Clinical Trial.
Cite
Cite